MF
Highly rated in
2
conditions
Highly rated in
2
conditions
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Mark H. Fishbein's experience treating your condition:
About Dr. Mark H. Fishbein

Mark Fishbein is a Pediatric Gastroenterologist in Chicago, Illinois. Fishbein is highly rated in 2 conditions, according to our data. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Gastroesophageal Reflux in Infants, Gastroesophageal Reflux Disease, and Obesity. He is licensed to treat patients in Illinois. Fishbein is currently accepting new patients.

His clinical research consists of co-authoring 41 peer reviewed articles and participating in 3 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mark H. Fishbein it is best to call his office and ask if your insurance is accepted.


Dr. Mark H. Fishbein accepts the following insurance:

  •  Ambetter
Locations
225 E Chicago Ave, Chicago, IL 60611
Other Locations
25 N. Winfield Road, East Entrance, Winfield, IL 60190
1870 Silver Cross Blvd, New Lenox, IL 60451
Winfield Rd, Winfield, IL 60190
Background & Education
Specialties
Pediatric Gastroenterology
Licenses
Pediatric Gastroenterology in IL
Hospital Affiliations
Northwestern Medicine Central DuPage Hospital
Ann & Robert H Lurie Childrens Hospital Of Chicago
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Database 2
Losartan for the Treatment of Pediatric NAFLD (STOP-NAFLD): A Phase 2, Randomized, Placebo-Controlled Clinical Trial
View 2 Less Clinical Trial -

41 Total Publications

NGS-Indel Coder v2.0: A Streamlined Pipeline to Code Indel Characters in Phylogenomic Data.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors